β¨ Medicines Consent Notices
8 APRIL 2004
NEW ZEALAND GAZETTE, No. 41
1023
Dated this 4th day of April 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).
go2327
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Recormon 10000 for Reco-Pen
Active Ingredient:
Epoetin beta 10,000IU
Dosage Form:
Powder for injection
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany
Product:
Recormon 20000 for Reco-Pen
Active Ingredient:
Epoetin beta 20,000IU
Dosage Form:
Powder for injection
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany
Product:
Recormon
Active Ingredient:
Epoetin beta 1,000IU
Dosage Form:
Solution for injection
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
Roche Diagnostics GmbH, Mannheim, Germany
Product:
Recormon
Active Ingredient:
Epoetin beta 2,000IU
Dosage Form:
Solution for injection
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
Roche Diagnostics GmbH, Mannheim, Germany
Product:
Recormon
Active Ingredient:
Epoetin beta 3,000IU
Dosage Form:
Solution for injection
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
Roche Diagnostics GmbH, Mannheim, Germany
Product:
Recormon
Active Ingredient:
Epoetin beta 4,000IU
Dosage Form:
Solution for injection
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
Roche Diagnostics GmbH, Mannheim, Germany
Product:
Recormon
Active Ingredient:
Epoetin beta 5,000IU
Dosage Form:
Solution for injection
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
Roche Diagnostics GmbH, Mannheim, Germany
Product:
Recormon
Active Ingredient:
Epoetin beta 500IU
Dosage Form:
Solution for injection
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
Roche Diagnostics GmbH, Mannheim, Germany
Product:
Recormon
Active Ingredient:
Epoetin beta 6,000IU
Dosage Form:
0.3 mL pre-filled syringe Solution for injection
New Zealand Sponsor:
Roche Products (New Zealand) Limited
Manufacturer:
Roche Diagnostics GmbH, Mannheim, Germany
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2004, No 41
Gazette.govt.nz —
NZ Gazette 2004, No 41
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of Changed Medicines
(continued from previous page)
π₯ Health & Social Welfare4 April 2004
Medicines, Distribution Consent, Recormon, Epoetin beta
- DON MATHESON, Deputy Director-General, Public Health